SureTrader SureTrader
Home > Boards > US OTC > Biotechs > Neuralstem Inc. (CUR)

Put your head back on your shoulder and

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 207
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/30/2016 4:06:30 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/28/2016 5:36:56 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2016 4:48:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2016 4:48:24 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/8/2016 8:03:30 AM
Neuralstem Reports Third Quarter 2016 Results "GlobeNewswire Inc." - 11/8/2016 7:35:00 AM
Neuralstem  Announces Presentations at Upcoming Scientific Conferences "GlobeNewswire Inc." - 11/2/2016 7:35:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/27/2016 4:06:52 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/21/2016 4:07:47 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/20/2016 4:06:34 PM
Neuralstem Presents NSI-189 Preclinical Neurocognitive Benefits at the Radiation Research Society Annual Meeting "GlobeNewswire Inc." - 10/20/2016 7:52:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/26/2016 4:52:56 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/26/2016 4:51:55 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/21/2016 4:02:24 PM
Neuralstem Achieves 50% Enrollment in NSI-189 Phase 2 Trial in Major Depressive Disorder "GlobeNewswire Inc." - 9/21/2016 8:32:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/12/2016 2:06:21 PM
Neuralstem Presented NSI-189 Preclinical Data in Type 1 and Type 2 Diabetes at the Annual Meeting of the Diabetic Neuropathy ... "GlobeNewswire Inc." - 9/12/2016 8:32:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/12/2016 8:04:12 AM
Neuralstem Receives $20,000,000 Strategic Investment from Tianjin Pharmaceutical Group "GlobeNewswire Inc." - 9/12/2016 8:03:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/1/2016 1:20:18 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2016 5:02:37 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2016 4:07:07 PM
Neuralstem Reports Second Quarter 2016 Results and Provides Business and Clinical Updates "GlobeNewswire Inc." - 8/11/2016 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2016 4:37:21 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/9/2016 4:32:03 PM
biomanbaba  Grandfathered Member Tuesday, 10/08/13 08:26:29 PM
Re: situps00 post# 1270
Post # of 4341 
Put your head back on your shoulder and use it for thinking

I am writing this to you now situps because it will become one of my most famous posts when I write my book in 2019. You are now part of the LEGEND

Forget the noise my friend and GO visit APRIL
http://thealsexpress.com/stem-cell-study/
This wonderful young woman is going to tell us IN REAL TIME how the most important Clinical Trial ever conducted in ALS is going.
Her progress and her blog are going to force the shorts here to beat their swords into plowshares and praise God.

These shares will be $10 by Christmass of 2013 and shareholders will have a Merry one. 2.20s are cheaper than dirt...load them
Who told you that?

T H E BIOMANBABA

Take your basis off on ANY run
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist